Skip to content

DENDROGENIX: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

DENDROGENIX

BE 0700.613.677
NACE 72.101, Research and development on biotechnology
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€2.3m
2024 · -€2.2m-€70,680
Equity
€3.3m
2024 · €5.6m-€2.3m
Cash
€3.3m
2024 · €1.4m+€1.8m
Balance sheet total
€5.3m
2024 · €7.7m-€2.4m

Largest movements

2024 to 2025
Assets
  • Current investments -€4.0m

    down €4.0m (-100.0%), from €4.0m to €0

  • Cash +€1.8m

    up €1.8m (+127.1%), from €1.4m to €3.3m

    mainly Current investments (+€4.0m) and Depreciation (+€2.1m)

  • Receivables within one year -€158,766

    down €158,766 (-22.7%), from €697,944 to €539,178

    of which Other amounts receivable: -€153,960

  • Deferred charges and accrued income -€76,801

    down €76,801 (-82.2%), from €93,435 to €16,635

Equity and liabilities
  • Profit (loss) carried forward -€2.3m

    down €2.3m, from €52,921 to -€2.2m

  • Debts after one year -€144,475

    down €144,475 (-8.6%), from €1.7m to €1.5m

  • Trade debts +€132,804

    up €132,804 (+58.1%), from €228,600 to €361,404

  • Tax, wage and social debts -€87,618

    down €87,618 (-47.4%), from €185,032 to €97,414

    of which Remuneration and social security: -€63,970

Income statement
  • Depreciation +€268,983

    up €268,983 (+14.9%), from €1.8m to €2.1m

  • Staff costs -€110,916

    down €110,916 (-10.6%), from €1.0m to €935,766

  • Gross operating margin +€60,997

    up €60,997 (+8.9%), from -€687,488 to -€626,490

  • Taxes -€11,209

    down €11,209 (-11.8%), from -€94,935 to -€106,144

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€2.2m
Gross operating margin +€60,997
Staff costs +€110,916
Depreciation -€268,983
Other operating charges -€3,953
Other operating items +€5,930
Financial income +€6,710
Financial charges +€6,494
Taxes +€11,209
Result 2025 -€2.3m

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€3,773
Investment +€2.0m
Financing -€150,385
Cash 2024 €1.4m
Net result for the year -€2.3m
Depreciation +€2.1m
Receivables after one year -€62,061
Receivables within one year +€158,766
Deferred charges and accrued income +€76,801
Trade debts +€132,804
Tax, wage and social debts -€87,618
Investment in fixed assets (net) -€2.0m
Current investments +€4.0m
Debts after one year -€144,475
Contributions, distributions and other -€5,909
Cash 2025 €3.3m
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €7,676,506 €5,277,538 -€2.4m -31.3%
Fixed assets 21/28 €1,095,361 €1,029,094 -€66,267 -6.0%
Intangible fixed assets 21 €972,716 €946,271 -€26,445 -2.7%
Tangible fixed assets 22/27 €122,110 €82,288 -€39,822 -32.6%
Plant, machinery and equipment 23 €116,849 €79,957 -€36,891 -31.6%
Furniture and vehicles 24 €5,261 €2,330 -€2,931 -55.7%
Financial fixed assets 28 €535 €535 = 0.0%
Current assets 29/58 €6,581,145 €4,248,444 -€2.3m -35.4%
Amounts receivable after more than one year 29 €341,573 €403,634 +€62,061 +18.2%
Other amounts receivable 291 €341,573 €403,634 +€62,061 +18.2%
Amounts receivable within one year 40/41 €697,944 €539,178 -€158,766 -22.7%
Trade receivables 40 €31,819 €27,012 -€4,807 -15.1%
Other amounts receivable 41 €666,125 €512,165 -€153,960 -23.1%
Current investments 50/53 €4,000,000 €0 -€4.0m -100.0%
Cash at bank and in hand 54/58 €1,448,192 €3,288,997 +€1.8m +127.1%
Deferred charges and accrued income 490/1 €93,435 €16,635 -€76,801 -82.2%
Total equity and liabilities 10/49 €7,676,506 €5,277,538 -€2.4m -31.3%
Equity 10/15 €5,590,720 €3,291,041 -€2.3m -41.1%
Contributions 10/11 €5,392,188 €5,392,188 = 0.0%
Capital 10 €5,392,188 €5,392,188 = 0.0%
Issued capital 100 €5,392,188 €5,392,188 = 0.0%
Reserves 13 €2,785 €2,785 = 0.0%
Non-distributable reserves 130/1 €2,785 €2,785 = 0.0%
Legal reserve 130 €2,785 €2,785 = 0.0%
Profit (loss) carried forward 14 €52,921 -€2,240,849 -€2.3m
Investment grants 15 €142,825 €136,916 -€5,909 -4.1%
Amounts payable 17/49 €2,085,786 €1,986,496 -€99,289 -4.8%
Amounts payable after more than one year 17 €1,672,154 €1,527,679 -€144,475 -8.6%
Other amounts payable 178/9 €1,672,154 €1,527,679 -€144,475 -8.6%
Amounts payable within one year 42/48 €413,632 €458,818 +€45,186 +10.9%
Trade debts 44 €228,600 €361,404 +€132,804 +58.1%
Suppliers 440/4 €228,600 €361,404 +€132,804 +58.1%
Taxes, remuneration and social security 45 €185,032 €97,414 -€87,618 -47.4%
Taxes 450/3 €23,647 €0 -€23,647 -100.0%
Remuneration and social security 454/9 €161,384 €97,414 -€63,970 -39.6%
Remuneration, social security and pensions 62 €1,046,682 €935,766 -€110,916 -10.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,809,867 €2,078,850 +€268,983 +14.9%
Other operating charges 640/8 €18,121 €22,074 +€3,953 +21.8%
Non-recurring operating charges 66A €5,930 €0 -€5,930 -100.0%
Gross operating margin 9900 -€687,488 -€626,490 +€60,997 +8.9%
Operating profit (loss) 9901 -€3,568,088 -€3,663,181 -€95,093 -2.7%
Financial income 75/76B €1,260,863 €1,267,573 +€6,710 +0.5%
Recurring financial income 75 €1,260,863 €1,267,573 +€6,710 +0.5%
Financial charges 65/66B €10,800 €4,306 -€6,494 -60.1%
Recurring financial charges 65 €10,800 €4,306 -€6,494 -60.1%
Profit (loss) for the period before taxes 9903 -€2,318,024 -€2,399,914 -€81,889 -3.5%
Income taxes 67/77 -€94,935 -€106,144 -€11,209 -11.8%
Profit (loss) for the period 9904 -€2,223,089 -€2,293,770 -€70,680 -3.2%
Profit (loss) for the period to be appropriated 9905 -€2,223,089 -€2,293,770 -€70,680 -3.2%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.